simeprevir

Subscribe to RSS - simeprevir

MD Magazine: UMass Medical School study says care access, medication adherence difficulties are barriers to treatment with new hepatitis C drugs

A UMass Medical School study finds people with hepatitis C may face barriers to treatment with new, expensive drugs that include access to care, difficulties with medication adherence and reluctance by physicians to treat them, according to an article in MD Magazine.

UMass Medical School study suggests hepatitis C patients face barriers to new drug treatments

A UMass Medical School study of Massachusetts Medicaid members suggests certain patients with hepatitis C face barriers to receiving the newest medications to treat the virus. The research paper published in the June edition of the Journal of Managed Care & Specialty Pharmacy says more patients must have access to the life-saving regimens.